Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
44.00
0.00
(0.00%)
As of 12:30:58 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-404,357
-414,333
-299,516
-142,522
8,943
Investing Cash Flow
-745,371
239,253
-262,134
-147,777
-196,515
Financing Cash Flow
1,097,027
221,317
516,166
319,980
234,124
End Cash Position
47,366
113,399
67,182
112,666
82,985
Interest Paid Supplemental Data
25,651
10,295
15,165
9,175
9,620
Capital Expenditure
-2,693
-1,416
-11,335
-48,872
-11,052
Issuance of Capital Stock
869,765
164,233
--
312,049
225,108
Issuance of Debt
--
--
523,586
--
--
Repayment of Debt
-6,926
-858
-188,925
--
--
Free Cash Flow
-407,050
-415,749
-310,851
-191,394
-2,109
12/31/2020 - 7/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2VJ.DU Ascletis Pharma Inc
0.7700
+4.76%
2VJ.BE Ascletis Pharma Inc
0.8200
+6.49%
ASCLF Ascletis Pharma Inc.
0.8388
0.00%
1VT.BE Viking Therapeutics Inc
27.29
+0.07%
1672.HK ASCLETIS-B
6.750
+8.87%
EWTX Edgewise Therapeutics, Inc.
25.08
+0.28%
ATNM Actinium Pharmaceuticals, Inc.
1.1500
-1.71%
BMEA Biomea Fusion, Inc.
2.8400
-14.97%
AKRO Akero Therapeutics, Inc.
47.47
-4.29%
ALT Altimmune, Inc.
5.91
-3.27%